ADVANCE®AI, a leading innovator in pharmaceutical-specific AI solutions, is excited to announce our acceptance into the Microsoft for Startups Pegasus Program. This collaboration provides ADVANCE®AI with access to powerful AI tools, Microsoft expertise, and a global customer network to help scale faster and smarter.
“Joining the Microsoft for Startups Pegasus Program is a game-changer,” said Gary Page, CEO of ADVANCE®AI. “We’re building the future of field-based healthcare professional listening in the pharmaceutical industry, and Microsoft’s technology and global reach give us the momentum to bring those insights to more pharmaceutical companies and improve patient outcomes faster.”
“We’re pleased to collaborate with ADVANCE®AI, a leading innovator in pharma-specific AI,” said Sally Ann Frank, Global Lead for Health and Life Sciences, Microsoft for Startups. “Their field-based healthcare professional listening technology is reshaping how life sciences teams understand and act on real-world conversations. Together, we can deliver AI-powered insights at scale, helping companies accelerate innovation and improve patient engagement.”
About ADVANCE®AI
ADVANCE®AI helps pharmaceutical companies identify the quality and impact of their field interactions between healthcare professionals (HCPs) and field representatives. By providing actionable insights by HCP segment, ADVANCE®AI enables pharmaceutical teams to optimize their engagement strategies for better results.
To learn more, visit https://advanceai.tech.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251124527926/en/
Contacts
Christine Duborg, SVP North & South America Client Relations at Advance AI, christine.duborg@advanceai.tech